Fever, a common symptom in clinical practice, often signals underlying infection or inflammation. Its management, however, can be complex due to varying etiologies and patient responses. This article aims to provide a comprehensive guide for managing fever in clinical practice.
Understanding the physiological mechanisms of fever is crucial. Fever results from an upward adjustment of the body's thermostat in the hypothalamus, often due to pyrogens. These may be exogenous, like bacterial toxins, or endogenous, such as cytokines. Understanding these mechanisms can aid in determining the cause of fever and guide treatment strategies.
Assessment of fever involves a thorough history, physical examination, and targeted investigations. Key aspects include duration, pattern, associated symptoms, and potential exposure to infectious agents. Depending on the clinical scenario, laboratory investigations may range from basic tests such as complete blood count and cultures, to more specific tests like serology or imaging.
Treatment of fever should be etiology-specific and patient-centered. Antipyretics, such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used. However, their use should be judicious, considering potential side effects. In fevers due to infection, appropriate antibiotics or antivirals should be employed. In non-infectious fevers, the underlying cause should be addressed.
Regular monitoring of the patient's temperature, response to treatment, and potential complications is essential. Follow-up is crucial, especially in cases where the fever is persistent or recurrent. This helps ensure that the chosen treatment strategy is effective and allows for adjustments as necessary.
Managing fever in clinical practice requires a comprehensive understanding of its mechanisms, thorough assessment, targeted treatment, and diligent follow-up. By adopting a systematic and patient-centered approach, clinicians can effectively manage fever, alleviating patient discomfort and potentially identifying and addressing serious underlying conditions.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation